Abstract
Charcot–Marie–Tooth (CMT) disease is the most common inherited neuromuscular disorder. Recent advancements in molecular biology have elucidated the molecular bases of this genetically heterogeneous neuropathy. Still, the major challenge lies in determining the individual contributions by malfunctions of proteins to the disease’s pathology. This paper reviews the identified molecular mechanisms underlying major forms of CMT disease. A growing body of evidence has highlighted the role of protein misfolding in demyelinating peripheral neuropathies and neurodegenerative diseases. Several hypotheses have been proposed to explain how misfolded aggregates induce neuronal damage. Current research focuses on developing novel therapeutic targets which aim to prevent, or even reverse the formation of protein aggregation. Interestingly, the role of the cellular defence mechanisms against accumulation of misfolded proteins may play a key role leading to novel strategies for treatment accelerating the clearance of their toxic early aggregates. Based on these findings we propose a model for describing in terms of a formal computer language, the biomolecular processes involving proteins associated with CMT disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alexiou AT, Psiha MM, Rekkas JA, Vlamos PM (2011) A stochastic approach of mitochondrial dynamics. World Acad Sci Eng Technol 79:77–81
Alexiou AT, Psiha MM, Vlamos PM (2011) A stochastic model for protein synthesis and activation through RNA-protein interaction in bioambients calculus. Comput Technol Appl 2:565–569
Barisic N, Claeys K, Sirotkovic-Skerlev M, Lfgren A, Nelis A, De Jonghe PEA (2008) Charcot–Marie–Tooth disease: a clinico-genetic confrontation. Ann Hum Genet 72(Pt 3):41641
Berciano A, Garca E, Gallardo C, Ramn, Combarros O (2009) Phenotype and clinical evolution of Charcot–Marie–Tooth disease type 1A duplication. Adv Exp Med Biol 652:183200
Berger P, Young P, Suter U (2002) Molecular cell biology of Charcot–Marie–Tooth disease. Neurogenetics 4(1):1–15
Bertolotti A, Zhang Y, Hendershot LM, Harding HP, Ron D (2000) Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response. Nat Cell Biol 2(6):326–332
Cao SS, Kaufman RJ (2012) Unfolded protein response. Curr Biol 22(16):R622–R626
Chen A, Muzzio IA, Malleret G, Bartsch D, Verbitsky M, Pavlidis P, Yonan AL, Vronskaya S, Grody MB, Cepeda I et al (2003) Inducible enhancement of memory storage and synaptic plasticity in transgenic mice expressing an inhibitor of atf4 (creb-2) and c/ebp proteins. Neuron 39(4):655–669
Chin L, Olzmann J, Li L (2008) Aggresome formation and neurodegenerative diseases: therapeutic implications. Curr Med Chem 15(1):47–60 (2008)
Chin LS, Lee SM, Li L (2013) Simple: a new regulator of endosomal trafficking and signaling in health and disease. Commun Integr Biol 6(3), 799–816 (2013)
Dyck PJ, Lambert EH (1968) Lower motor and primary sensory neuron diseases with peroneal muscular atrophy: I. neurologic, genetic, and electrophysiologic findings in hereditary polyneuropathies. Arch Neurol 18(6):603
Eylar EH, Uyemura K, Brostoff SW et al (1979) Proposed nomenclature for pns myelin proteins. Neurochem Res 4(2):289–293
Fontana W, Buss LW (1996) The barrier of objects: from dynamical systems to bounded organizations. Citeseer
Fortun WA, Dunn Jr S, Joy JL, Notterpek L (2003) Emerging role for autophagy in the removal of aggresomes in Schwann cells. J Neurosci 23(33):10672–10680
Fortun J, Go JC, Li J, Amici SA, Dunn Jr WA, Notterpek L (2006) Alterations in degradative pathways and protein aggregation in a neuropathy model based on PMP22 overexpression. Neurobiol Dis 22(1):153–164
Greenfield S, Brostoff S, Eylar EH, Morell P (1973) Protein composition of myelin of the peripheral nervous system. J Neurochem 20(4):1207–1216
Haze K, Yoshida H, Yanagi H, Yura T, Mori K (1999) Mammalian transcription factor atf6 is synthesized as a transmembrane protein and activated by proteolysis in response to endoplasmic reticulum stress. Mol Biol Cell 10(11):3787–3799
Jessen KR, Mirsky R (2008) Negative regulation of myelination: relevance for development, injury, and demyelinating disease. Glia 56(14):1552–1565
Juárez P, Palau F (2012) Neural and molecular features on Charcot–Marie–Tooth disease plasticity and therapy. Neural Plast 2012. Article ID 171636, 11 pages, 2012. doi:10.1155/2012/171636
Kamholz J, Awatramani R, Menichella D, Jiang H, Xu W, Shy M (1999) Regulation of myelin-specific gene expression: relevance to CMT1. Ann N Y Acad Sci 883(1):91–108
Krajewski K, Lewis R., Fuerst D et al (2000) Neurological dysfunction and axonal degeneration in Charcot–Marie–Tooth disease type 1a. Brain 44:1299–1304
Lee YC, Lin KP, Chang MH, Liao YC, Tsai CP, Liao KK, Soong BW (2010) Cellular characterization of mpz mutations presenting with diverse clinical phenotypes. J Neurol 257(10):1661–1668
Lee SM, Olzmann JA, Chin LS, Li L (2011) Mutations associated with Charcot–Marie–Tooth disease cause SIMPLE protein mislocalization and degradation by the proteasome and aggresome–autophagy pathways. J Cell Sci 124(19):3319–3331
Lee SM, Chin LS, Li L (2012) Protein misfolding and clearance in demyelinating peripheral neuropathies: therapeutic implications. Commun Integr Biol 5(1):107–110
Matsumoto H, Miyazaki S, Matsuyama S, Takeda M, Kawano M, Nakagawa H, Nishimura K, Matsuo S (2013) Selection of autophagy or apoptosis in cells exposed to ER-stress depends on ATF4 expression pattern with or without chop expression. Biol Open 2(10):1084–1090
Milner R (1999) Communicating and mobile systems: the pi calculus. Cambridge University Press, Cambridge
Nishitoh H, Saitoh M, Mochida Y, Takeda K, Nakano H, Rothe M, Miyazono K, Ichijo H (1998) Ask1 is essential for JNK/SAPK activation by TRAF2. Mol Cell 2(3):389–395
Pareek S, Notterpek L, Snipes GJ, Naef R, Sossin W, Laliberté J, Iacampo S, Suter U, Shooter EM, Murphy RA (1997) Neurons promote the translocation of peripheral myelin protein 22 into myelin. J Neurosci 17(20):7754–7762
Pareyson D, Marchesi C (2009) Diagnosis, natural history, and management of Charcot–Marie–Tooth disease. Lancet Neurol 8(7):654–667
Patzkó Á, Bai Y, Saporta MA, Katona I, Wu X, Vizzuso D, Feltri ML, Wang S, Dillon LM, Kamholz J et al (2012) Curcumin derivatives promote Schwann cell differentiation and improve neuropathy in R98C CMT1B mice. Brain 135(12):3551–3566
Pennuto M, Tinelli E, Malaguti M, Del Carro U, D’Antonio M, Ron D, Quattrini A, Feltri ML, Wrabetz L (2008) Ablation of the UPR-mediator CHOP restores motor function and reduces demyelination in Charcot–Marie–Tooth 1b mice. Neuron 57(3):393–405
Pennuto M, Tinelli E, Malaguti M et al (2008) Ablation of the UPR-mediator CHOP restores motor function and reduces demyelination in Charcot–Marie–Tooth 1b mice. Neuron 57(3):393–405
Rajesh K, Papadakis AI, Kazimierczak U, Peidis P, Wang S, Ferbeyre G, Kaufman RJ, Koromilas AE (2013) eIF2α phosphorylation bypasses premature senescence caused by oxidative stress and pro-oxidant antitumor therapies. Aging 5(12):884
Regev A, Shapiro E (2004) The π-calculus as an abstraction for biomolecular systems. In: Modelling in molecular biology. Springer, Berlin, pp 219–266
Regev A, Silverman W, Shapiro E (2001) Representation and simulation of biochemical processes using the pi-calculus process algebra. Pac Symp Biocomput 6:459–470
Ron D, Walter P (2007) Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 8(7):519–529
Rutkowski DT, Kaufman RJ (2004) A trip to the ER: coping with stress. Trends Cell Biol 14(1):20–28
Ryan MC, Shooter EM, Notterpek L (2002) Aggresome formation in neuropathy models based on peripheral myelin protein 22 mutations. J Peripher Nervous System 7(4):246–246 (2002)
Samali A, FitzGerald U, Deegan S, Gupta S (2010) Methods for monitoring endoplasmic reticulum stress and the unfolded protein response. Int J Cell Biol p 830307
Saporta MA, Shy BR, Patzko A, Bai Y, Pennuto M, Ferri C, Tinelli E, Saveri P, Kirschner D, Crowther M et al (2012) Mpzr98c arrests Schwann cell development in a mouse model of early-onset Charcot–Marie–Tooth disease type 1b. Brain 135(7):2032–2047
Shen J, Chen X, Hendershot L, Prywes R (2002) Er stress regulation of ATF6 localization by dissociation of BiP/GRP78 binding and unmasking of Golgi localization signals. Dev Cell 3(1):99–111
Teske BF, Wek SA, Bunpo P, Cundiff JK, McClintick JN, Anthony TG, Wek RC (2011) The eIF2 kinase PERK and the integrated stress response facilitate activation of ATF6 during endoplasmic reticulum stress. Mol Biol Cell 22(22):4390–4405
Urano F, Wang X, Bertolotti A, Zhang Y, Chung P, Harding HP, Ron D (2000) Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science 287(5453):664–666
Verfaillie T, Salazar M, Velasco G, Agostinis P (2010) Linking ER stress to autophagy: potential implications for cancer therapy. Int J Cell Biol 2010, Article ID 930509, 19 pages, 2010. doi:10.1155/2010/930509
Wang S, Kaufman RJ (2012) The impact of the unfolded protein response on human disease. J Cell Biol 197(7):857–867
Yoshida H, Matsui T, Hosokawa N, Kaufman RJ, Nagata K, Mori K (2003) A time-dependent phase shift in the mammalian unfolded protein response. Dev Cell 4(2):265–271
Züchner S, Vance JM (2006) Molecular genetics of autosomal-dominant axonal Charcot–Marie–Tooth disease. Neuromol Med 8(1–2):63–74
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this paper
Cite this paper
Theocharopoulou, G., Vlamos, P. (2015). Modeling Protein Misfolding in Charcot–Marie–Tooth Disease. In: Vlamos, P., Alexiou, A. (eds) GeNeDis 2014. Advances in Experimental Medicine and Biology, vol 820. Springer, Cham. https://doi.org/10.1007/978-3-319-09012-2_7
Download citation
DOI: https://doi.org/10.1007/978-3-319-09012-2_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-09011-5
Online ISBN: 978-3-319-09012-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)